Agile Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $13.8M

  • Investors
  • 7

Agile Bio General Information

Description

Developer of biomedical automation equipment designed for fluid monitoring and automatic control. The company integrates the solution of industrial chromatographic separation and purification, and the automated R&D and production of clinical mass spectrometry pretreatment, providing overall solutions for extraction, separation, and purification for biopharmaceutical customers.

Contact Information

Website
agilebio.com.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor, Northwest Area, Nano City
  • No. 99, Jinjihu Avenue
  • Suzhou, Jiangsu 215000
  • China
+86 0512
Primary Industry
Biotechnology
Other Industries
Machinery (B2B)
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 2nd Floor, Northwest Area, Nano City
  • No. 99, Jinjihu Avenue
  • Suzhou, Jiangsu 215000
  • China
+86 0512

Agile Bio Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Agile Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 01-Sep-2023 $13.8M Completed Generating Revenue
3. Early Stage VC (Series A) 25-Mar-2022 Completed Generating Revenue
2. Early Stage VC 16-Jan-2022 Completed Generating Revenue
1. Early Stage VC 03-Mar-2021 Completed Generating Revenue
To view Agile Bio’s complete valuation and funding history, request access »

Agile Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Agile Bio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Jiaxing Jiarui Investment Venture Capital Minority
Cowin Capital Venture Capital Minority
Oriza Holdings Asset Manager Minority
Shangshi Capital Venture Capital Minority
Trinity Innovation Fund Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Agile Bio FAQs

  • When was Agile Bio founded?

    Agile Bio was founded in 2020.

  • Where is Agile Bio headquartered?

    Agile Bio is headquartered in Suzhou, China.

  • What is the size of Agile Bio?

    Agile Bio has 29 total employees.

  • What industry is Agile Bio in?

    Agile Bio’s primary industry is Biotechnology.

  • Is Agile Bio a private or public company?

    Agile Bio is a Private company.

  • What is Agile Bio’s current revenue?

    The current revenue for Agile Bio is .

  • How much funding has Agile Bio raised over time?

    Agile Bio has raised $13.8M.

  • Who are Agile Bio’s investors?

    Jiaxing Jiarui Investment, Cowin Capital, Oriza Holdings, Shangshi Capital, and Trinity Innovation Fund are 5 of 7 investors who have invested in Agile Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »